(1 - 17 from 23
)
Injectable PrEP could be 'discreet' HIV prevention option for womenwww.healio.com › news › infectious-disease › injectable-prep-could-be-dis...
www.healio.com
Jan 27, — Sinead Delany-Moretlwe, MBBCh, PhD, DTM&H, a researcher at the University of the Witwatersrand in Johannesburg, presented findings from the ...
On World AIDS Day, South Africa finds hope in new treatment
apnews.com
Dec 1, — Dr. Sinead Delany-Moretlwe, director of research at the Johannesburg-based Reproductive Health and HIV Institute (RHI), looks on during an ... › article
HIV Prevention is Failing Young South African Women | Inter Press...
www.ipsnews.net
Professor Sinead Delany-Moretlwe, director for research at Wits Reproductive Health and HIV Institute (Wits RHI) in Johannesburg, describes ...
Kenya to Conduct Trial on New HIV Prevention Drug for Women
genderandaids.unwomen.org
“The development of safe alternative options for PrEP could increase HIV prevention choices for women,” said Sinead Delany-Moretlwe, chair of the study at the Witwatersrand in Johannesburg, South Africa. HPTN 084 trial is jointly funded through a partnership of the US National Institute of Allergy and ...
sorted by relevance / date